Longevity Health Holdings, Stock Operating Margin
| XAGE Stock | 0.83 0.08 10.67% |
Fundamental analysis of Longevity Health allows traders to better anticipate movements in Longevity Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (89.40) | (93.87) |
Longevity | Operating Margin | Build AI portfolio with Longevity Stock |
Longevity Health Holdings, Company Operating Margin Analysis
Longevity Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Longevity Health Operating Margin | (2.95) % |
Most of Longevity Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Longevity Health Holdings, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Longevity Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Longevity Health is extremely important. It helps to project a fair market value of Longevity Stock properly, considering its historical fundamentals such as Operating Margin. Since Longevity Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Longevity Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Longevity Health's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Longevity Health Holdings, has an Operating Margin of -2.9524%. This is 91.06% lower than that of the Biotechnology sector and 119.72% lower than that of the Health Care industry. The operating margin for all United States stocks is 46.42% lower than that of the firm.
Longevity Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Longevity Health's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Longevity Health could also be used in its relative valuation, which is a method of valuing Longevity Health by comparing valuation metrics of similar companies.Longevity Health is currently under evaluation in operating margin category among its peers.
Longevity Fundamentals
| Return On Asset | -0.67 | ||||
| Operating Margin | (2.95) % | ||||
| Current Valuation | 5.14 M | ||||
| Shares Outstanding | 1.48 M | ||||
| Shares Owned By Insiders | 13.57 % | ||||
| Shares Owned By Institutions | 4.93 % | ||||
| Number Of Shares Shorted | 8.83 K | ||||
| Price To Sales | 10.56 X | ||||
| Revenue | 50.32 K | ||||
| Gross Profit | 313.78 K | ||||
| EBITDA | (10.5 M) | ||||
| Net Income | (11.8 M) | ||||
| Total Debt | 638.99 K | ||||
| Book Value Per Share | (3.79) X | ||||
| Cash Flow From Operations | (4.39 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (11.87) X | ||||
| Number Of Employees | 10 | ||||
| Beta | 0.56 | ||||
| Market Capitalization | 5.92 M | ||||
| Total Asset | 1.47 M | ||||
| Retained Earnings | (68.87 M) | ||||
| Working Capital | (4.92 M) | ||||
| Net Asset | 1.47 M |
About Longevity Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Longevity Health Holdings,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longevity Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longevity Health Holdings, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Longevity Health Hol is a strong investment it is important to analyze Longevity Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Longevity Health's future performance. For an informed investment choice regarding Longevity Stock, refer to the following important reports:Check out Longevity Health Piotroski F Score and Longevity Health Altman Z Score analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longevity Health. If investors know Longevity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longevity Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Longevity Health Hol is measured differently than its book value, which is the value of Longevity that is recorded on the company's balance sheet. Investors also form their own opinion of Longevity Health's value that differs from its market value or its book value, called intrinsic value, which is Longevity Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longevity Health's market value can be influenced by many factors that don't directly affect Longevity Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longevity Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longevity Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longevity Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.